Local understanding of an HIV vaccine and its relationship with HIV-related stigma in the Dominican Republic

被引:21
作者
Barrington, C.
Moreno, L.
Kerrigan, D.
机构
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth Int Hlth, Baltimore, MD 21205 USA
[2] COIN, Santo Domingo, Dominican Rep
来源
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV | 2007年 / 19卷 / 07期
基金
美国国家卫生研究院;
关键词
AIDS VACCINE; TRIALS; WILLINGNESS; PARTICIPATE; KNOWLEDGE; RISK; POPULATION; ACCEPTANCE; BARRIERS; ISSUES;
D O I
10.1080/09540120701203295
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purpose of this study was to explore local perceptions and experiences regarding vaccines in general and HIV vaccines and vaccine trials in the Dominican Republic. In- depth interviews were carried out with 25 participants representing two study groups: (1) individuals considered at high risk for HIV infection including female sex workers and male STI clinic attendees and (2) individuals considered at low risk of HIV infection including women and men recruited at a general outpatient clinic. Across the groups, participants often characterized vaccines in general as having both preventive and curative properties. In turn, one of the most salient concerns regarding the receipt of an HIV vaccine was the fear that one would be labelled 'HIV positive' and stigmatized, as the vaccine may be perceived as a cure for those already infected. These findings suggest the importance of individual and community level education to clarify the nature and mechanisms of the given HIV vaccine being tested. Social support and counselling services should also accompany HIV vaccine trials and distribution plans to assist individuals in determining if and how they communicate their participation and/ or receipt of an HIV vaccine to others and manage potential negative social reactions.
引用
收藏
页码:871 / 877
页数:7
相关论文
共 20 条
[1]   Determinants of enrollment in a preventive HIV vaccine trial [J].
Buchbinder, SP ;
Metch, B ;
Holte, SE ;
Scheer, S ;
Coletti, A ;
Vittinghoff, E .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (01) :604-612
[2]  
CHESNEY MA, 1995, J ACQ IMMUN DEF SYND, V9, P30
[3]   Factors associated with the acceptance of an AIDS vaccine: an exploratory study [J].
Crosby, RA ;
Holtgrave, DR ;
Bryant, L ;
Frew, PM .
PREVENTIVE MEDICINE, 2004, 39 (04) :804-808
[4]  
*HVTN, 2006, POSS VACC OUTC
[5]  
*IAVI, 2006, QUEST ANSW VACC AIDS
[6]   Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations [J].
Kilmarx, PH ;
Ramjee, G ;
Kitayaporn, D ;
Kunasol, P .
AIDS, 2001, 15 :S73-S79
[7]   Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials - A population-based study, Rakai, Uganda [J].
Kiwanuka, N ;
Robb, M ;
Kigozi, G ;
Birx, D ;
Philips, J ;
Wabwire-Mangen, F ;
Wawer, MJ ;
Nalugoda, F ;
Sewankambo, NK ;
Serwadda, D ;
Gray, RH .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) :721-725
[8]  
Koblin BA, 2000, J ACQ IMMUN DEF SYND, V24, P451, DOI 10.1097/00126334-200008150-00010
[9]   ETHICAL, BEHAVIORAL, AND SOCIAL ASPECTS OF HIV VACCINE TRIALS IN DEVELOPING-COUNTRIES [J].
LURIE, P ;
BISHAW, M ;
CHESNEY, MA ;
COOKE, M ;
FERNANDES, MEL ;
HEARST, N ;
KATONGOLEMBIDDE, E ;
KOETSAWANG, S ;
LINDAN, CP ;
MANDEL, J ;
MHLOYI, M ;
COATES, TJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (04) :295-301
[10]  
McGrath JW, 2001, J ACQ IMMUN DEF SYND, V27, P381, DOI 10.1097/00126334-200108010-00009